S
0.100
0.00 (0.00%)
Penutupan Terdahulu | 0.100 |
Buka | 0.100 |
Jumlah Dagangan | 103,200 |
Purata Dagangan (3B) | 893,606 |
Modal Pasaran | 48,404,500 |
Harga / Jualan (P/S) | 0.630 |
Harga / Buku (P/B) | 0.680 |
Julat 52 Minggu |
Margin Keuntungan | -11.07% |
Margin Operasi (TTM) | -17.71% |
EPS Cair (TTM) | -0.020 |
Pertumbuhan Hasil Suku Tahunan (YOY) | -75.70% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 7.54% |
Nisbah Semasa (MRQ) | 2.25 |
Aliran Tunai Operasi (OCF TTM) | -1.90 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | 4.26 M |
Pulangan Atas Aset (ROA TTM) | -5.21% |
Pulangan Atas Ekuiti (ROE TTM) | -13.15% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Scientific & Technical Instruments (MY) | Bercampur | Bercampur |
Scientific & Technical Instruments (Global) | Bercampur | Bercampur | |
Stok | SOLUTN | - | - |
AISkor Stockmoo
0.6
Konsensus Penganalisis | 0.0 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | 3.5 |
Purata Bergerak Teknikal | 0.0 |
Osilator Teknikal | -1.0 |
Purata | 0.63 |
Saham Serupa
Stok | Modal Pasaran | DY | P/E (TTM) | P/B |
---|---|---|---|---|
SOLUTN | 48 M | - | - | 0.680 |
CREST | 173 M | 1.95% | 6.50 | - |
Solution Group Bhd is an investment holding company. Its operating segments include Engineering Equipment, Industrial Automation, Metal Fabrication and Assembly, Green and Renewable Energy, Biopharmaceuticals, Investment, and Others. Geographically, the company serves Malaysian as well as Overseas customers. It has three manufacturing sites, two located in Selangor and one in Kuala Lumpur. |
|
Sektor | Technology |
Industri | Scientific & Technical Instruments |
Gaya Pelaburan | Small Value |
% Dimiliki oleh Orang Dalam | 58.51% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tarikh | Jenis | Butiran |
---|---|---|
01 Jul 2025 | Pengumuman | INTERNATIONAL EXCLUSIVE DISTRIBUTION AGREEMENT BETWEEN SOLUTION BIOLOGICS SDN BHD ("SOLBIO"), A WHOLLY-OWNED SUBSIDIARY OF SOLUTION GROUP BERHAD ("SGB" or "the Company") AND XIAMEN INNOVAX BIOTECH CO., LTD ("INNOVAX") FOR THE SUPPLY OF THE RECOMBINANT HUMAN PAPILLOMAVIRUS BIVALENT VACCINE. |
29 May 2025 | Pengumuman | General Meetings: Outcome of Meeting |
29 May 2025 | Pengumuman | Quarterly rpt on consolidated results for the financial period ended 31/03/2025 |
30 Apr 2025 | Pengumuman | Annual Report & CG Report - 2024 |
30 Apr 2025 | Pengumuman | Notice of Interest Sub. S-hldr (Section 137 of CA 2016) - DATUK LIM NYUK SANG @ FREDDY LIM |
30 Apr 2025 | Pengumuman | STATEMENT TO SHAREHOLDERS IN RELATION TO THE PROPOSED RENEWAL OF SHARE BUY-BACK AUTHORITY |
29 Apr 2025 | Pengumuman | General Meetings: Notice of Meeting |
21 Apr 2025 | Pengumuman | SOLUTION GROUP BERHAD ("THE COMPANY") - Proposed Renewal of Share Buy-Back Authority |
Tarikh EX | Tarikh Pengumuman | Tarikh Pembayaran | Perincian |
---|---|---|---|
10 Mar 2022 | 24 Feb 2022 | 23 Mar 2022 | 0.02 Tunai |
Hasil Dividen Tahunan
Tahun | Dividen Tahunan ($) | Kekerapan/Tahun | Hasil % |
---|---|---|---|
2022 | 0.020 | 1 | 6.56 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |